Capsule endoscopy developer CapsoVision files $30M IPO
Through a Nasdaq IPO—under the ticker “CV”—CapsoVision aims to add AI imaging programs with a new FDA clearance by the end of this year.
Through a Nasdaq IPO—under the ticker “CV”—CapsoVision aims to add AI imaging programs with a new FDA clearance by the end of this year.
